ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,655Medicare Part D Prescriptions Filled, Including Refills

Rank: 55 out of 2343

$1.14M Total Retail Price of All Prescriptions

Rank: 76 out of 2343

735 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 735 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

3% of this provider’s 20,522 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
OMEPRAZOLE 1,218 1,148 1 4
AMLODIPINE BESYLATE 1,146 1,054 2 5
SIMVASTATIN 1,060 1,025 3 1
ATELVIA 1,031 1,006 10 4 234
ALENDRONATE SODIUM 878 866 5 28
FENOFIBRATE 671 636 6 94
METFORMIN HCL 662 617 7 9
LOVASTATIN 624 615 8 47
TAMSULOSIN HCL 547 534 9 29
METOPROLOL TARTRATE 495 468 10 7
GLYBURIDE-METFORMIN HCL 438 412 R 11 154
ATORVASTATIN CALCIUM 406 393 12 10
LOSARTAN-HYDROCHLOROTHIAZIDE 358 334 13 64
ATENOLOL 335 334 14 12
LISINOPRIL 327 297 15 3
AVODART 307 302 16 165
GLIMEPIRIDE 305 280 17 45
DIOVAN HCT 304 302 18 63
TRICOR 296 289 19 96
RANITIDINE HCL 282 267 20 43
CELEBREX 276 269 21 71
LEVOTHYROXINE SODIUM 275 265 22 2
LOSARTAN POTASSIUM 256 230 23 19
NEXIUM 243 230 24 33
TRIAMTERENE-HCTZ 235 225 25 57
PRAVASTATIN SODIUM 232 226 26 15
BENICAR HCT 209 209 27 156
LEVOCETIRIZINE DIHYDROCHLORIDE 209 202 27 223
ATENOLOL-CHLORTHALIDONE 164 152 29 190
LISINOPRIL-HYDROCHLOROTHIAZIDE 159 153 30 42
ZOLPIDEM TARTRATE 157 147 31 24
MELOXICAM 151 149 32 68
AZITHROMYCIN 150 137 33 39
HYDROCHLOROTHIAZIDE 150 136 33 11
EVISTA 148 148 35 128
WARFARIN SODIUM 147 135 36 8
FLUTICASONE PROPIONATE 143 113 37 46
AMLODIPINE BESYLATE-BENAZEPRIL 128 124 38 59
DIOVAN 128 128 38 23
PLAVIX 125 122 40 38
PANTOPRAZOLE SODIUM 124 124 41 22
FINASTERIDE 122 122 42 80
VESICARE 119 112 43 145
BENICAR 119 119 43 93
CLOPIDOGREL 115 115 45 26
ADVAIR DISKUS 108 101 46 34
JANUVIA 102 102 47 50
BETAMETHASONE DIPROPIONATE 98 86 48 284
LANTUS 97 81 49 51
CLOTRIMAZOLE-BETAMETHASONE 95 95 50 127
ISOSORBIDE MONONITRATE ER 95 85 50 32
DONEPEZIL HCL 92 91 52 21
SERTRALINE HCL 90 90 53 20
ZOSTAVAX 89 85 54 236
AMOXICILLIN 89 84 54 118
CICLOPIROX 89 88 54 387
ACTONEL 88 88 57 182
LOVAZA 84 84 58 113
DESOXIMETASONE 83 83 59 503
SYMBICORT 82 82 60 167
NAMENDA 78 78 61 36
ENALAPRIL MALEATE 75 75 62 58
MECLIZINE HCL 74 74 63 103
HUMALOG 73 60 64 131
PATANOL 69 54 65 310
IBUPROFEN 69 52 65 75
VENTOLIN HFA 68 55 67 79
GLIPIZIDE XL 67 67 68 84
SPIRIVA 65 54 69 48
NIFEDIPINE ER 64 64 70 89
FUROSEMIDE 63 60 71 6
CIPROFLOXACIN HCL 61 54 72 72
DIGOXIN 60 48 73 35
CARVEDILOL 60 60 73 27
PEN NEEDLE 60 60 73 119
GEMFIBROZIL 57 57 76 133
TRIAMCINOLONE ACETONIDE 56 49 77 137
INSULIN SYRINGE 56 53 77 102
NAPROXEN 54 39 79 108
DICLOFENAC SODIUM 54 46 79 155
SINGULAIR 51 34 81 100
DOXAZOSIN MESYLATE 50 49 82 98
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 12, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.